Nexome Genomics Inc.
Cloud-based genomic analytics platform for precision medicine and disease diagnosis
- Sector
- Biotech
- Headquarters
- GAITHERSBURG, MD
- Founded
- 2016
- Latest Form D
- $300K offered, Apr 2021
- Total capital
- $378K
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $300K
- 1 Form D · last Apr 2021
- 67 months since last filing
- Federal contracts
- $78K
- 6 awards · Health and Human S
- Rank in Biotech#340 of 4373
- Granted patents
- None on recordNo USPTO grants. Applications publish after 18 months.
Capital timeline
Latest events
- Offering registeredForm D · SEC · 1st filing$300K
- Federal contractHealth and Human S · Nexome Genomics Customized Fish Probe Panels$17K
- Federal contractHealth and Human S · NXG-LSP005-160-A$11K
- Federal contractHealth and Human S · Nexome Genomics INC.:1308194 [19-005508]$14K
- Federal contractHealth and Human S · Nexome Genomics INC.:1308194 [18-053452]$12K
- Federal contractHealth and Human S · Nexome Genomics INC.:1308194 [18-033677]$15K
- Federal contractHealth and Human S · Nexome Genomics INC.:1308194 [18-038102]$10K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Federal first
33months
from Nexome Genomics Inc.’s first federal award to its first private round.
- First federal award · Jul 2018
- Health and Human S · $10K
- First Form D · Apr 2021
- $300K · 1st Form D
- Awards before first raise
- 6 awards
An association in public records, not a cause or a prediction.
Founders and team
From SEC Form D filings- Yun-Sheng TsaiExecutive Officer, Director, PromoterNamed in SEC Form D filings
What it has protected
No granted patents are on record.
USPTO usually publishes applications 18 months after filing, so recent applications may not be visible yet. Patents assigned under a different entity name won’t match.
Checked: USPTO granted patents and published applications · Oct 23, 2026
Related companies, and why
- Celularity IncSimilar federal contract value in Biotech · $80K in contracts
- AUM LIFETECH INCSimilar federal contract value in Biotech · $80K in contracts
- PRIMETIME LIFE SCIENCES, LLCSimilar federal contract value in Biotech · $79K in contracts
- ORA BIOMEDICAL, INC.Similar federal contract value in Biotech · $75K in contracts
- Agios PharmaceuticalsSimilar federal contract value in Biotech · $73K in contracts
- BIOLYTIC LAB PERFORMANCE, INC.Similar federal contract value in Biotech · $72K in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .